Hyaluronic acid is a natural polysaccharide found abundantly throughout the body with many desirable properties for application as a biomaterial, including scaffolding for tissue engineering. In this work, hyaluronic acid with molecular weights ranging from 50 to 1100 kDa was modified with methacrylic anhydride and photopolymerized into networks with a wide range of physical properties. With macromer concentrations from 2 to 20 wt %, networks exhibited volumetric swelling ratios ranging from ∼42 to 8, compressive moduli ranging from ∼2 to over 100 kPa, and degradation times ranging from less than 1 day up to almost 38 days in the presence of 100 U/mL of hyaluronidase. When 3T3-fibroblasts were photoencapsulated in the hydrogels, cells remained viable with low macromer concentrations but decreased sequentially as the macromer concentration increased. Finally, auricular swine chondrocytes produced neocartilage when photoencapsulated in the hyaluronic acid networks. This work presents a next step toward the development of advanced in vivo curable biomaterials.
Introduction
Tissue engineering is emerging as a viable treatment alternative to allogenic and alloplastic implants for cartilage damage. Numerous materials have been investigated as scaffolding for the delivery of chondrocytes to damaged cartilage including collagen 1 , fibrin, 2,3 alginate, 4, 5 poly(Rhydroxy esters), 6, 7 and hyaluronic acid. 8 Although this research has led to significant advances in cartilage tissue regeneration, novel scaffolds that optimize the amount and quality of neocartilage produced need to be developed.
Elisseeff and co-workers 9 were the first to report a photopolymerization process to suspend chondrocytes in hydrogel networks for tissue regeneration. Chondrocyte photoencapsulation is advantageous due to the ease of filling irregular shaped defects, which leads to good contact between the tissue engineered construct and surrounding native tissue. This technique allows for the noninvasive implantation of chondrocyte/polymer constructs by exposing prepolymer solutions containing cytocompatible photoinitiators to low intensity visible or ultraviolet light. These efforts have focused primarily on photopolymerizable hydrogels based on poly(ethylene glycol) (PEG). Bryant et al. 10 introduced lactic acid units into the PEG networks to accelerate hydrogel degradation and enhance extracellular matrix distribution in the engineered tissue.
Hyaluronic acid (HA) is a linear polysaccharide of alternating D-glucuronic 
acid and N-acetyl-D-glucosamine,
found in connective tissues such as cartilage. It degrades in the presence of hyaluronidases and free radicals and functions as a core molecule for the binding of keratin sulfate and chondroitin sulfate in forming aggrecans in cartilage. 11 Although not completely understood, HA plays a role in cellular processes including cell proliferation, morphogenesis, inflammation, and wound repair. Several cell surface receptors for HA include CD44, ICAM-1, and RHAMM. 12, 13 In addition, HA is readily modified through both its carboxyl 14 and hydroxyl [15] [16] [17] [18] groups. These properties make HA a desirable choice for the fabrication of chondrocyte carrier materials in cartilage regeneration, with hydrogel degradation controlled by a cell dictated enzymatic process instead of a hydrolytic one. Recently, Setton and co-workers 19 illustrated the ability to encapsulate articular chondrocytes in one photopolymerizable HA network in vivo.
The overall objective of this study is to combine the benefits of a photocrosslinkable network with the desirable properties of HA for future application in cartilage tissue engineering. This manuscript systematically studies the effects of HA molecular weight, the degree of methacrylation and macromer concentration on the physical properties (e.g., swelling, mechanics, and degradation) of the resulting hydrogels. In addition, photoencapsulated cell viability and neocartilage tissue formation were investigated as a preliminary test for the potential use of photopolymerizable HA networks as chondrocyte carriers for cartilage regeneration.
Materials and Methods
Macromer Synthesis and Polymerization. Methacrylated hyaluronic acid (MeHA) was synthesized by the addition of methacrylic anhydride (Sigma, ∼20-fold excess) to a solution of 1 wt % HA (Lifecore, MW ) 50, 350, and 1100 kDa) in deionized water adjusted to a pH of 8 with 5 N NaOH (Aldrich) and reacted on ice for 24 h. This synthesis was previously described, 18 and the structure is shown in Figure  1 . For purification, the macromer solution was dialyzed (MW cutoff 5-8 kDa) against deionized water for at least 48 h, and the final product was obtained by lyophilization. Poly-(ethylene glycol) dimethacrylate (PEGDM) was synthesized by the addition of methacryloyl chloride (Sigma) and triethylamine (Aldrich) to PEG (Polysciences, hydroxyl end groups, MW ) 4 kDa) dissolved in methylene chloride (Aldrich) on ice, as previously described. 20 The final product was purified by repeated dissolution in methylene chloride and precipitation in diethyl ether (Aldrich).
1 H NMR (Varian Unity-300) was used to determine the final functionality and purity of the MeHA (in D 2 O) and PEGDM (in CDCl 3 ) macromers. Hydrogels were fabricated by dissolving the MeHA and PEGDM macromers at various concentrations in phosphate buffered saline (PBS) containing 0.05 wt % 2-methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, I2959), pipetting between glass slides with a 1 mm spacer, and polymerizing with the addition of ∼4 mW/cm 2 ultraviolet light for 10 min using a longwave ultraviolet lamp (model 100AP, Blak-Ray).
Hydrogel Characterization. After polymerization and swelling in PBS for 48 h to equilibrium, hydrogel disks were weighed (wet weight) and then dried (dry weight) to determine the volumetric swelling ratio (Q V ), which is reported as the ratio of the wet weight to the dry weight (n ) 3 per composition) and assuming a density of 1.23 g/cm 3 for the MeHA macromers. 16 The compressive modulus of the various swollen hydrogels was determined on an Instron 5542 mechanical tester using a parallel plate apparatus and loading of 10% of the initial thickness per minute (∼200 µm/min). Samples for mechanical testing (n ) 5 per composition) were cylindrical (∼2 mm height, ∼7 mm diameter) and were compressed until failure or until 60% of the initial thickness was reached. The modulus was determined as the slope of the stress versus strain curve at low strains (<20%).
For degradation analysis, polymer disks (1 mm thickness, 9 mm diameter) were punched from hydrogel slabs using stainless steel bores. Samples (n ) 3 per composition) were degraded in solutions of either 10 or 100 U hyaluronidase (Sigma) per mL of PBS (replaced every 48 h throughout the study and stored frozen until analysis) at 37°C on an orbital shaker. The time for complete degradation of the hydrogel disks is reported. The amount of uronic acid (a degradation component of HA) released during degradation was measured using a previously established carbazole reaction technique. 21 Briefly, 100 µL of the degradation solution was added to a concentrated sulfuric acid/sodium tetraborate decahydrate (Sigma) solution and heated to 100°C for 10 min. After adding 100 µL of 0.125% carbazole (Sigma) in absolute ethanol and heating to 100°C for 15 min, the solution absorbance at 530 nm was measured. The amount of uronic acid was determined using solutions of known concentrations of the 50 kDa HA as a standard. The percent of total uronic acid released at each time point is reported. Degradation products were also analyzed with 1 H NMR to determine if any unreacted or partially reacted monomer was present.
Photoencapsulated Cell Viability. As an initial assessment of photoencapsulated cell viability, 3T3-fibroblasts (ATCC, passage 5) were encapsulated by suspending in 50 µL (∼5 mm diameter, ∼2 mm height) of macromer solution (containing 0.05 wt % I2959) and polymerizing with the addition of ∼4 mW/cm 2 ultraviolet light for 10 min using a longwave ultraviolet lamp (model 100AP, Blak-Ray). These conditions were previously determined to be cytocompatible for photoencapsulating chondrocytes. 22 The viability of photoencapsulated fibroblasts (40 × 10 6 cells/ml) was assessed immediately after encapsulation and after 1 week of in vitro culture (DMEM, 10% fetal bovine serum, Invitrogen) using a commercially available MTT viability assay (ATCC, 30-1010K). For this assay, 100 µL of the provided MTT reagent (tetrazolium salt solution) was added directly to the wells containing the constructs (n ) 3 per macromer solution) and placed in an incubator at 37°C for 4 h. The purple formazen produced by active mitochondria was solubilized by construct homogenization in 1 mL of the provided detergent solution and orbital shaking for 2 h. The absorbance of these solutions was then read at 570 nm (Molecular Devices SpectraMax 384).
Chondrocyte Isolation and Photoencapsulation. Swine aged 3-6 months were euthanized using an overdose of Pentobarbital (100 mg/kg IV) and cartilage tissue was harvested in a sterile fashion. The harvested auricular cartilage was cut into ∼1 mm 3 pieces, washed in PBS, and digested for 18 h at 37°C in a sterile 0.1% collagenase (Worthington) solution in Ham's F-12 medium. After digesting, the solution was passed through a 100 µm filter to remove undigested cartilage and centrifuged. The chondrocytes were washed twice with PBS and counted using a hemacytometer, and the viability was determined using trypan blue exclusion prior to encapsulation. Chondrocytes were photoencapsulated in the various hydrogel networks (40 × 10 6 chondrocytes/ml) by suspension in the desired macromer solution, pipetting into a sterile mold (50 µL volume), and polymerization as described above.
In Vivo Tissue Formation. Hydrogel constructs containing photoencapsulated chondrocytes were placed into subcutaneous pockets in the dorsum of nude mice (4 implants per mouse). Male nude mice (5-6 weeks old, ∼25 g, nu/ nu, Massachusetts General Hospital) were used for all studies. After 4, 6, and 8 weeks, mice were euthanized and constructs were harvested for histological or biochemical analysis. For histological analysis, constructs were fixed in 10% formalin for 24 h, embedded in paraffin, and processed using standard histological staining procedures. The histological sections were stained with Safranin O to visualize glycosaminoglycans (GAG). For biochemical analysis, constructs (n ) 5) were digested in a papain solution (125 µg/mL papain type III, 10 mM l-cysteine, 100 mM phosphate, and 10 mM EDTA at pH 6.3) for 15 h at 60°C. Total DNA content was determined using a bisbenzimidazol fluorescent dye (Hoechst 33258) method 23 added at a concentration of 0.2 mg/mL in 0.01 M Tris, 1 mM EDTA, and 0.1 M NaCl with chondrocyte number determined using a conversion factor of 7.7 pg of DNA per chondrocyte. Total GAG content was determined using the dimethylmethylene blue dye method 24 and normalized to chondrocyte number. All reagents for biochemical analysis were obtained from Aldrich unless stated otherwise.
Statistical Analysis. Statistical analysis was performed using a Student's t-test (only to compare two individual groups) with a minimum confidence level of 0.05 for statistical significance. All values are reported as the mean and standard error of the mean.
Results and Discussion
Network Synthesis. HA networks were fabricated from MeHA precursors with varying molecular weights and methacrylations and with different MeHA concentrations to determine the range of properties possible for these potentially useful biomaterials. As illustrated in Figure 1 , the MeHA macromers undergo a free radical polymerization with the addition of light and an initiator to form a cross-linked hydrogel that consists of HA and kinetic chains of poly-(methacrylic acid). The various MeHA solutions investigated in this work are summarized in Table 1 . Although the MeHA macromers were synthesized using the same techniques and with the same concentrations of HA and methacrylic anhydride, a slightly higher methacrylation was obtained with the 50 kDa HA. This is potentially explained due to decreased viscosity during this reaction compared to the 350 and 1100 kDa HA, increasing the mobility of various species during the reaction. The macromer concentrations investigated were chosen as the highest concentrations of MeHA that could still be pipetted into molds or for suspending cells. For instance, this was only possible up to 2 wt % of the 1100 kDa MeHA macromer but was possible for a 10-fold higher amount of the 50 kDa macromer, allowing for a wider range of network properties.
Network Swelling, Mechanics, and Degradation. The equilibrium volumetric swelling ratios of the various HA networks are shown in Figure 2 . As expected, a decrease in Q V is seen with an increase in the concentration of macromer in the precursor solutions. For example, Q V is ∼41 for networks fabricated from 2 wt % of the 50 kDa macromer but decreases to ∼8 when the macromer concentration is increased 10-fold to 20 wt %. The same trend is seen for the 350 kDa macromer. For each molecular weight, there is a statistically significant (p > 0.05) decrease in Q V with an increase in macromer concentration, but there were no statistical differences between the different MeHA molecular weights when the same concentration of macromer was used for network formation. Using Flory-Rehner calculations, 16, 25 the network mesh size and the cross-linking density, which are important when explaining mechanics and degradation, are directly correlated to Q V .
Stress versus strain curves for several of the investigated networks are shown in Figure 3 . The general slope is linear at low strains (<20%) and then increases with an increase in strain. Overall, the modulus (i.e., slope of stress versus strain curve at low strain) correlates well with the network cross-linking density (i.e., swelling). As the macromer concentration increases for each MeHA molecular weight, a statistically significant increase in the modulus is seen. For instance, networks fabricated from 2 wt % of the 50 kDa macromer had a modulus of only ∼12 kPa, but increased substantially to ∼100 kPa when the macromer concentration was increased to 20 wt %.
The overall time for complete degradation of the networks in a solution of 100 U hyaluronidase/ml of PBS is shown in In general, the swollen networks decreased in size throughout the degradation and exposure to the hyaluronidase. This behavior was previously seen for other crosslinked hyaluronic acid hydrogels. 26 This is potentially due to both an increase in erosion at the surface of the gels due to diffusion restrictions of the enzyme into the interior of the gel and an attraction of positively charged groups produced during degradation and the negatively charged carboxylic acid groups of the HA. Again, there was good correlation between degradation time and the hydrogel crosslinking density. For example, an increase in macromer concentration extended the time for complete degradation in a dose-dependent fashion. Also, no measurable double bonds were found during NMR analysis of the degradation products, indicating that the radical polymerization reaches near 100% conversion with the initiation conditions used (i.e., 10 min, 10 mW/cm 2 , 0.05 wt % I2959). It should be noted that these results only give information regarding relative degradation times and do not represent actual times for in vivo degradation, which is dependent on the actual local enzyme concentration.
The amount of uronic acid in the degradation solutions is shown in Figure 5 and plotted as the overall percentage of uronic acid detected with degradation time. For networks formed with the 50 kDa MeHA macromer, an increase in the macromer concentration (i.e., cross-linking density) extended the time for complete uronic acid release. For the 5 wt % HA network, ∼40% of uronic acid is detected within 2 days of degradation and then a near linear release of uronic acid is observed until complete degradation. For the 10 wt % HA network, ∼50% of the uronic acid is detected in the first 5 days of degradation, yet degradation extends to almost 20 days. A burst is observed at the end of degradation, due to the rapid solubilization of kinetic chains and HA when the network becomes loosely cross-linked. The rapid uronic acid release at short degradation periods could be due to the release of HA with low methacrylation, as a distribution of methacrylations is expected throughout the MeHA macromers. As seen in Figure 5B , the overall time and rate of hydrogel degradation is faster with a higher enzyme concentration (100 versus 10 U/ml).
Cell Encapsulation and Viability. 3T3-fibroblasts were encapsulated in the various networks and their viability was determined both immediately after encapsulation and after 1 week of in vitro culture. These results are shown in Figure  6 . Immediately after polymerization, a range of fibroblast viability is noted, with a decrease in viability as the macromer concentration increased. This could potentially be attributed to an increase in the radical concentration during encapsulation due to an increase in the reactive group concentration (i.e., methacrylates) in the precursor solutions with higher macromer concentrations. The reduction in MeHA molecular weight did not seem to affect the viability of the encapsulated cells. After 1 week of culture, a further decrease in viability is seen with many of the macromer solutions, especially with the more highly cross-linked ones. For the 50 kDa macromer, a statistically significant decrease in viability is found with each increase in macromer concentration. The high crosslinking density can decrease the ability for nutrients and wastes to be exchanged between the encapsulated cells and surrounding culture media and lead to compromised cell viability. In general, the highest and sustained viability was observed in both the 1100 and 50 kDa macromers at 2 wt %. Fluorescent live/dead staining (results not shown) indicated that >95% of the encapsulated cells in these gels remained viable. Overall, these results indicate that although the higher macromer concentrations led to desirable mechanical properties, their application as cell carriers is limited due to low viability of photoencapsulated cells. It should be noted that photopolymerizable HA networks could find use in many biological applications including drug delivery, fabrication of microfluidic devices, biomaterials surface modifications, and for tissue engineering as porous scaffolding.
Neocartilage Formation. Primary auricular swine chondrocytes were photoencapsulated in one of the HA hydrogels (2 wt % 350kDa MeHA) that allowed high viability of photoencapsulated fibroblasts to assess the potential of these HA hydrogels for cartilage regeneration. PEGDM, which has been extensively investigated as a photo-cross-linkable carrier for chondrocytes, 27, 28 was used as a control. Even after culture in the dorsum of nude mice for only 4 weeks, all of the constructs became more opaque as neocartilage tissue filled the networks. When auricular chondrocytes were encapsulated, the constructs resembled native cartilage with a white, shiny appearance. Representative stains for glycosaminoglycans (GAG) are shown in Figure 7 . Although light background staining is observed for control HA networks without cells (results not shown), a more intense staining was observed when neocartilage was produced in the gels. When MeHA was used for network formation the GAG is evenly distributed throughout the tissue, whereas the GAG is confined primarily to the pericellular regions for the networks formed from PEGDM. This behavior is anticipated since the PEG networks can actually prevent the distribution of large extracellular matrix molecules since the networks are nondegradable. Thus, the cell controlled degradation of the HA networks may be crucial in optimizing cartilaginous tissue formation and distribution. When quantified (Figure 7 ), changes in GAG production (reported as ng chondroitin sulfate per encapsulated chondrocyte) are seen with culture time. After 12 weeks, GAG values represent ∼75% of those found for native articular cartilage from the same swine used for chondrocyte isolation (results not shown). There is little difference between the overall amount of GAG produced by chondrocytes in the MeHA versus PEGDM hydrogels, but the histology suggests there is a significant difference in the distribution of this tissue. As a control, the GAG content was determined for all hydrogels immediately after chondrocyte photoencapsulation and almost no GAG is detected, indicating very little interference by the HA hydrogels in this assay. Overall, these in vivo results indicate that further work should be pursued to investigate these HA hydrogels as chondrocyte carriers in cartilage tissue engineering.
Conclusions
This work presents a systematic study of the ability to fabricate photopolymerizable HA networks with a wide range of properties. Specifically, alterations in the HA molecular weight allowed high macromer concentrations to be incorporated in the precursor solution, leading to networks with high cross-linking densities. Although networks with a compressive modulus over 100 kPa were formed, the viability of fibroblasts in these networks was compromised potentially due to restrictions in nutrient transport through the network and a high radical concentration during polymerization. However, in the less cross-linked networks, viability was sustained and swine chondrocytes produced neocartilage tissue when implanted subcutaneously in nude mice. The variability in macromer molecular weight at concentrations that promoted cell viability will allow for a wide variety of precursor solution viscosities, which will be important for clinical and noninvasive implantation of these gels.
